This variant modulates TP53 gene regulation, at transcriptional and post-transcriptional levels as indicated by eQTL and sQTL analyses, with decreased TP53 expression correlating with a reduced risk of overall HNSCC. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.